The underlying mechanism of SEP was involved in the increased activity of TLR4/STAT3/CD64 signaling in macrophages, and provided some evidence for its potential clinical development as immunoprophylaxis or adjunct antimicrobial agents for infection. This evidence concerns the gene STAT3 and infection.